Loading resource…

International Initiative on Thrombosis and Cancer (ITAC)
The guidelines are developed by the International Initiative on Thrombosis and Cancer (ITAC) advisory panel, which aims to establish global consensus on managing cancer-associated thrombosis. The recommendations include the use of low-molecular-weight heparins and direct oral anticoagulants for treating and preventing venous thromboembolism in cancer patients. The guidelines also address specific considerations for patients with COVID-19 and highlight the importance of individualized treatment plans based on patient risk factors.
No account needed